Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in CHD patients with prior PCI
NCT00235950Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2004
- Primary completion
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in coronary heart disease (CHD), sponsored by AstraZeneca. Started Jan 2004; status: completed.
02
Drugs
rosuvastatin
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00235950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235950.